Contact Us marketing@medicilon.com
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
SERVICES
SERVICES
01 Drug Discovery
Chemistry Research Biology Research Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates Active Pharmaceutical Ingredients Pharmaceutical preparation Analytical Method Development and Quality Control CMC Filings Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics Drug Safety Evaluation DMPK Bioanalysis IND Filings
PLATFORM
PLATFORM
01 One-stop Integrated Services
Liposome Drug Development Drug Discovery Pharmaceutical Research Preclinical Research Botanical Drug Preclinical R&D
02 Innovative Drug R&D Services
Peptide Drug Conjugate (PDC) Antibody Nucleic Acid Drug Cellular Immunotherapies mRNA Vaccine PROTAC ADC
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection Metabolite Identification (MetID) Drug Forming Research Flow Cytometry Technology SEND Format Conversion Flow Sorting NanoString nCounter Detection Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Inflammatory and Immune Diseases IO Pharmacodynamic Model
05 High-end Preparations Technology Platform
Skin Topical Preparation Ophthalmic drug Inhalation drug
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service KRAS-targeted Drugs R&D Service GLP-1 New Drug R&D Service
07 Safety Assessment Lab of Process Chemistry

08 Public Services
CAREERS
Talent Development
Campus Recruitment
Recruitment
NEWS
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
INVESTORS
Stock Information
Investment Contact
CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
CN
×
中
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jul 23,2021
Pharmaceutical Stability Test
The stability of a drug substance or preparation refers to its ability to maintain physical, chemical, biological and microbiological properties. Stability research is based on the systematic research and understanding of APIs or preparations and their production processes. The quality characteristics of APIs or preparations obtained through design tests will vary under the influence ofRead more
More
Pharmaceutical Stability Test
Jul 22,2021
Medicilon appoints Dr. Xuedong Dai as Executive Vice President of International Discovery Service Unit
Recently, Shanghai Medicilon Inc. (stock code: 688202.SH) (Medicilon) announced the appointment of Dr. Xuedong Dai as Executive Vice President of International Discovery Service Unit. Dr. Xuedong Dai Executive Vice President of International Discovery Service Unit Dr. Xuedong Dai, Ph.D. in Organic Chemistry and Postdoctoral at MIT, has been deeply involved in the research and developmentRead more
More
Medicilon appoints Dr. Xuedong Dai as Executive Vice President of International Discovery Service Unit
Jul 22,2021
What is Accelerated Stability Testing?
The accelerated stability test places perishable products under stress to estimate the shelf life under normal conditions. In this test, the company encourages the product to fail in a short period of time in harsh environments, and use this to estimate what might happen under normal conditions. This eliminates the need to store the productRead more
More
What is Accelerated Stability Testing?
Jul 22,2021
New star in protein targeted degradation technology-LYTAC
Targeted protein degradation technology (Proteolysis TArgeting Chimeras, PROTAC) is an emerging hot drug development area following small molecule inhibitors (SMI) and monoclonal antibody (mAb) drugs. Compared with the latter two, PROTAC has unique advantages, being able to target numerous protein molecules that were previously considered "undruggable”. Hundreds of PROTAC molecules have been or are beingRead more
More
New star in protein targeted degradation technology-LYTAC
Jul 21,2021
The Second Generation LYTAC Technology
Targeted protein degradation is a very promising treatment, and it is also an important tool for discovering cell biology pathways and apoptosis mechanisms. Many methods for targeted protein degradation have been established, such as targeted induced protein degradation technology (PROTAC), autophagy targeted chimera (AUTAC), etc., but most of these methods target proteins in the cytoplasm.Read more
More
Jul 21,2021
PROTAC and LYTAC
Most drugs block or modulate the function of the target protein by binding to a specific site of the target protein. However, the activity of many proteins cannot be changed in this way. Protein degradation agents represented by Proteolis-Targeting Chimaeras (PROTACs) can change the function of proteins in an unconventional way. This new type ofRead more
More
Jul 13,2021
Ligand Binding Analysis of Drug Screening Methods
The acquisition of lead compounds and the production of drugs are important links in the process of drug screening. Drug screening involves a series of steps to select the most suitable chemical entity for drug development to clinical application, including pharmacological research and toxicological research. Research to determine the safety and effectiveness of the drug.Read more
More
Ligand Binding Analysis of Drug Screening Methods
Jul 13,2021
Caenorhabditis elegans, a model animal for studying the regulation of serotonin in the brain
With the continuous improvement of biological science and technology, the current models constructed using model organisms are playing an increasingly important role in drug screening. Patients with depression and anxiety often have lower levels of serotonin in their bodies. For these patients, some drugs that increase serotonin levels are often used clinically. Serotonin, also knownRead more
More
Caenorhabditis elegans, a model animal for studying the regulation of serotonin in the brain
Jul 13,2021
Scientists have discovered a new anti-cancer drug-EBV protein inhibitor
Epstein-Barr virus (EBV) is a herpes virus that is pathogenic to humans. It has been found to be associated with nasopharyngeal cancer, some gastric cancer, laryngeal cancer and Hodgkin's lymphoma. Although the proportion of EB virus directly causing cancer is very low, because of the high proportion of human infections, the eradication of cancer causedRead more
More
Scientists have discovered a new anti-cancer drug-EBV protein inhibitor
Jul 13,2021
Aloe-emodin inhibits tumor cell activity
Anthraquinone compounds are one of the important active components of aloe, which mainly include aloe emodin, chrysophanol, emodin, rhein acid and emodin methyl ether. A large number of cell experiments have shown that the anthraquinone compound aloe emodin can inhibit tumor cell proliferation and induce tumor cell apoptosis by blocking cell cycle. Therefore, the researchRead more
More
Aloe-emodin inhibits tumor cell activity
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(781)535-1428(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->